USD 0.0
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2022 | - USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 762.3 Thousand USD | 64998.29% |
2019 | 1171.00 USD | -99.47% |
2018 | 222.18 Thousand USD | 13.69% |
2017 | 195.43 Thousand USD | 33.71% |
2016 | 146.16 Thousand USD | 15.1% |
2015 | 126.98 Thousand USD | 0.0% |
2007 | 3.7 Million USD | 14.85% |
2006 | 3.22 Million USD | 98.46% |
2005 | 1.62 Million USD | 9743.68% |
2004 | 16.5 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q1 | 1149.65 USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2021 Q3 | 1.06 Million USD | -1.24% |
2021 FY | - USD | -100.0% |
2021 Q1 | 1.03 Million USD | 0.0% |
2021 Q2 | 1.08 Million USD | 4.84% |
2020 FY | 762.3 Thousand USD | 64998.29% |
2019 FY | 1171.00 USD | -99.47% |
2018 FY | 222.18 Thousand USD | 13.69% |
2017 FY | 195.43 Thousand USD | 33.71% |
2016 FY | 146.16 Thousand USD | 15.1% |
2015 FY | 126.98 Thousand USD | 0.0% |
2008 Q2 | 3.45 Million USD | 2.45% |
2008 Q1 | 3.37 Million USD | -8.78% |
2007 Q2 | 3.38 Million USD | 8.01% |
2007 Q1 | 3.13 Million USD | -2.66% |
2007 FY | 3.7 Million USD | 14.85% |
2007 Q3 | 3.28 Million USD | -3.04% |
2007 Q4 | 3.7 Million USD | 12.67% |
2006 Q3 | 3.26 Million USD | 32.57% |
2006 Q4 | 3.22 Million USD | -1.34% |
2006 Q2 | 2.46 Million USD | 4.04% |
2006 Q1 | 2.36 Million USD | 45.84% |
2006 FY | 3.22 Million USD | 98.46% |
2005 Q3 | 41 Thousand USD | 9.33% |
2005 Q1 | 34 Thousand USD | 0.0% |
2005 Q4 | 1.62 Million USD | 3861.48% |
2005 Q2 | 37.5 Thousand USD | 10.29% |
2005 FY | 1.62 Million USD | 9743.68% |
2004 FY | 16.5 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
American Medical Technologies Inc. | 2.34 Million USD | 100.0% |
Ansell Limited | 1.32 Billion USD | 100.0% |
Ansell Limited | 1.33 Billion USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | 126.33 Million USD | 100.0% |
CB Scientific, Inc. | 943.17 Thousand USD | 100.0% |
Psykey, Inc. | 2.47 Million USD | 100.0% |
ConvaTec Group Plc | 2.01 Billion USD | 100.0% |
ConvaTec Group Plc | 2.02 Billion USD | 100.0% |
Encision Inc. | 1.98 Million USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | 3.04 Million USD | 100.0% |
Innovative MedTech Inc. | 6.13 Million USD | 100.0% |
LifePoint, Inc. | 2.45 Million USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 3.4 Million USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | 3.04 Million USD | 100.0% |
Reflect Scientific, Inc. | 776.32 Thousand USD | 100.0% |
SmileDirectClub, Inc. | 982.26 Million USD | 100.0% |
Sector 10, Inc. | 9.84 Million USD | 100.0% |
Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 100.0% |
SheerVision, Inc. | 1.43 Million USD | 100.0% |
United Health Products, Inc. | 1.99 Million USD | 100.0% |
Vasamed, Inc. | 1 Million USD | 100.0% |
Wearable Health Solutions, Inc. | 3.8 Million USD | 100.0% |
Yubo International Biotech Limited | 2.91 Million USD | 100.0% |